VERMILION ENERGY INC (VET.CA) Fundamental Analysis & Valuation

TSX:VET • CA9237251058

Current stock price

18.24 CAD
-0.12 (-0.65%)
Last:

This VET.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. VET.CA Profitability Analysis

1.1 Basic Checks

  • VET had negative earnings in the past year.
  • VET had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: VET reported negative net income in multiple years.
  • VET had a positive operating cash flow in each of the past 5 years.
VET.CA Yearly Net Income VS EBIT VS OCF VS FCFVET.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

1.2 Ratios

  • VET's Return On Assets of -12.23% is on the low side compared to the rest of the industry. VET is outperformed by 61.54% of its industry peers.
  • Looking at the Return On Equity, with a value of -29.42%, VET is doing worse than 62.02% of the companies in the same industry.
  • VET's Return On Invested Capital of 2.66% is in line compared to the rest of the industry. VET outperforms 55.77% of its industry peers.
  • VET had an Average Return On Invested Capital over the past 3 years of 2.94%. This is below the industry average of 6.78%.
Industry RankSector Rank
ROA -12.23%
ROE -29.42%
ROIC 2.66%
ROA(3y)-5.6%
ROA(5y)4.29%
ROE(3y)-12.97%
ROE(5y)11.06%
ROIC(3y)2.94%
ROIC(5y)8.19%
VET.CA Yearly ROA, ROE, ROICVET.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

1.3 Margins

  • VET has a Operating Margin (9.59%) which is in line with its industry peers.
  • VET's Operating Margin has declined in the last couple of years.
  • VET has a better Gross Margin (67.50%) than 82.69% of its industry peers.
  • VET's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.59%
PM (TTM) N/A
GM 67.5%
OM growth 3Y-44.92%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y5.3%
VET.CA Yearly Profit, Operating, Gross MarginsVET.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. VET.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VET is destroying value.
  • Compared to 1 year ago, VET has less shares outstanding
  • The number of shares outstanding for VET has been reduced compared to 5 years ago.
  • The debt/assets ratio for VET is higher compared to a year ago.
VET.CA Yearly Shares OutstandingVET.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
VET.CA Yearly Total Debt VS Total AssetsVET.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.45, we must say that VET is in the distress zone and has some risk of bankruptcy.
  • VET has a Altman-Z score (0.45) which is in line with its industry peers.
  • VET has a Debt/Equity ratio of 0.58. This is a neutral value indicating VET is somewhat dependend on debt financing.
  • VET has a Debt to Equity ratio (0.58) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 0.45
ROIC/WACC0.33
WACC7.98%
VET.CA Yearly LT Debt VS Equity VS FCFVET.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • VET has a Current Ratio of 0.84. This is a bad value and indicates that VET is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.84, VET is in line with its industry, outperforming 56.73% of the companies in the same industry.
  • VET has a Quick Ratio of 0.84. This is a bad value and indicates that VET is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VET has a Quick ratio (0.76) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.76
VET.CA Yearly Current Assets VS Current LiabilitesVET.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. VET.CA Growth Analysis

3.1 Past

  • The earnings per share for VET have decreased strongly by -1316.67% in the last year.
  • The Revenue has decreased by -2.65% in the past year.
  • Measured over the past years, VET shows a quite strong growth in Revenue. The Revenue has been growing by 9.12% on average per year.
EPS 1Y (TTM)-1316.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2283.33%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y-19.75%
Revenue growth 5Y9.12%
Sales Q2Q%26.17%

3.2 Future

  • VET is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.47% yearly.
  • VET is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.27% yearly.
EPS Next Y110.61%
EPS Next 2Y48.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.29%
Revenue Next 2Y-1.18%
Revenue Next 3Y1.92%
Revenue Next 5Y0.27%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VET.CA Yearly Revenue VS EstimatesVET.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
VET.CA Yearly EPS VS EstimatesVET.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

3

4. VET.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • VET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 40.43, VET can be considered very expensive at the moment.
  • VET's Price/Forward Earnings is on the same level as the industry average.
  • VET is valuated expensively when we compare the Price/Forward Earnings ratio to 22.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 40.43
VET.CA Price Earnings VS Forward Price EarningsVET.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VET indicates a rather cheap valuation: VET is cheaper than 91.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.42
VET.CA Per share dataVET.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • VET's earnings are expected to grow with 48.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.47%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. VET.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.69%, VET has a reasonable but not impressive dividend return.
  • VET's Dividend Yield is a higher than the industry average which is at 4.47.
  • VET's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.69%

5.2 History

  • The dividend of VET decreases each year by -3.03%.
  • VET has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of VET decreased in the last 3 years.
Dividend Growth(5Y)-3.03%
Div Incr Years2
Div Non Decr Years2
VET.CA Yearly Dividends per shareVET.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of VET are negative and hence is the payout ratio. VET will probably not be able to sustain this dividend level.
DP-15.06%
EPS Next 2Y48.47%
EPS Next 3YN/A
VET.CA Yearly Income VS Free CF VS DividendVET.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B -1.5B

More info and screens

Find the best dividend stocksShow peers with best dividend

VET.CA Fundamentals: All Metrics, Ratios and Statistics

VERMILION ENERGY INC

TSX:VET (3/25/2026, 7:00:00 PM)

18.24

-0.12 (-0.65%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-04
Earnings (Next)N/A
Inst Owners51.27%
Inst Owner ChangeN/A
Ins Owners0.51%
Ins Owner ChangeN/A
Market Cap2.79B
Revenue(TTM)1.85B
Net Income(TTM)-653.60M
Analysts70.67
Price Target14.84 (-18.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.69%
Yearly Dividend0.64
Dividend Growth(5Y)-3.03%
DP-15.06%
Div Incr Years2
Div Non Decr Years2
Ex-Date03-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-913.05%
Min EPS beat(2)-1765.7%
Max EPS beat(2)-60.4%
EPS beat(4)0
Avg EPS beat(4)-913.27%
Min EPS beat(4)-1768.81%
Max EPS beat(4)-58.17%
EPS beat(8)0
Avg EPS beat(8)-518.9%
EPS beat(12)2
Avg EPS beat(12)-406.34%
EPS beat(16)4
Avg EPS beat(16)857.14%
Revenue beat(2)1
Avg Revenue beat(2)-3.71%
Min Revenue beat(2)-17.37%
Max Revenue beat(2)9.96%
Revenue beat(4)1
Avg Revenue beat(4)-9.65%
Min Revenue beat(4)-26.83%
Max Revenue beat(4)9.96%
Revenue beat(8)1
Avg Revenue beat(8)-11.12%
Revenue beat(12)1
Avg Revenue beat(12)-10.33%
Revenue beat(16)4
Avg Revenue beat(16)-2.99%
PT rev (1m)2.56%
PT rev (3m)7.74%
EPS NQ rev (1m)-3.03%
EPS NQ rev (3m)113.33%
EPS NY rev (1m)-25.97%
EPS NY rev (3m)-16.51%
Revenue NQ rev (1m)-0.47%
Revenue NQ rev (3m)1.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 40.43
P/S 1.51
P/FCF N/A
P/OCF 2.96
P/B 1.26
P/tB 1.26
EV/EBITDA 4.42
EPS(TTM)-4.25
EYN/A
EPS(NY)0.45
Fwd EY2.47%
FCF(TTM)-5.1
FCFYN/A
OCF(TTM)6.17
OCFY33.83%
SpS12.07
BVpS14.53
TBVpS14.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.23%
ROE -29.42%
ROCE 3.7%
ROIC 2.66%
ROICexc 2.67%
ROICexgc 2.67%
OM 9.59%
PM (TTM) N/A
GM 67.5%
FCFM N/A
ROA(3y)-5.6%
ROA(5y)4.29%
ROE(3y)-12.97%
ROE(5y)11.06%
ROIC(3y)2.94%
ROIC(5y)8.19%
ROICexc(3y)3%
ROICexc(5y)8.24%
ROICexgc(3y)3%
ROICexgc(5y)8.24%
ROCE(3y)4.08%
ROCE(5y)11.37%
ROICexgc growth 3Y-52.06%
ROICexgc growth 5YN/A
ROICexc growth 3Y-52.06%
ROICexc growth 5YN/A
OM growth 3Y-44.92%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y5.3%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA 1.4
Cap/Depr 231.87%
Cap/Sales 93.37%
Interest Coverage 1.35
Cash Conversion 102.52%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.76
Altman-Z 0.45
F-Score5
WACC7.98%
ROIC/WACC0.33
Cap/Depr(3y)142.57%
Cap/Depr(5y)140.06%
Cap/Sales(3y)58.41%
Cap/Sales(5y)46.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1316.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2283.33%
EPS Next Y110.61%
EPS Next 2Y48.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y-19.75%
Revenue growth 5Y9.12%
Sales Q2Q%26.17%
Revenue Next Year-2.29%
Revenue Next 2Y-1.18%
Revenue Next 3Y1.92%
Revenue Next 5Y0.27%
EBIT growth 1Y-25.05%
EBIT growth 3Y-55.8%
EBIT growth 5YN/A
EBIT Next Year118.97%
EBIT Next 3Y37.44%
EBIT Next 5YN/A
FCF growth 1Y-334.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.49%
OCF growth 3Y-19.58%
OCF growth 5Y13.54%

VERMILION ENERGY INC / VET.CA Fundamental Analysis FAQ

What is the fundamental rating for VET stock?

ChartMill assigns a fundamental rating of 3 / 10 to VET.CA.


Can you provide the valuation status for VERMILION ENERGY INC?

ChartMill assigns a valuation rating of 3 / 10 to VERMILION ENERGY INC (VET.CA). This can be considered as Overvalued.


How profitable is VERMILION ENERGY INC (VET.CA) stock?

VERMILION ENERGY INC (VET.CA) has a profitability rating of 3 / 10.


What is the earnings growth outlook for VERMILION ENERGY INC?

The Earnings per Share (EPS) of VERMILION ENERGY INC (VET.CA) is expected to grow by 110.61% in the next year.